Clinical Trials Browser

Phase 1/2 × lumretuzumab × Thoracic × Clear all

NCT02204345 2017-01-25

A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology

Phase 1/2 Terminated

Squamous Non-Small Cell Lung Cancer